A carregar...
A Phase 2 Study of Weekly Albumin-Bound Paclitaxel (Abraxane(®)) Given as a Two-Hour Infusion
PURPOSE: Paclitaxel is an effective therapy for patients with solid tumors. While the albumin-bound formulation eliminates the hypersensitivity reaction caused by the Cremaphor solvent, significant peripheral neuropathy persists when given over the standard 30-minute infusion time. We sought to dete...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3581346/ https://ncbi.nlm.nih.gov/pubmed/21461889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1621-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|